Scott T. Megaffin

Scott T. Megaffin

Chief Executive Officer at
Adiso Therapeutics, Inc.
63 year
Health Technology
Consumer Services
Commercial Services

Profile

Scott T.
Megaffin
is currently the Chief Executive Officer at Adiso Therapeutics, Inc. and a Trustee at BioNJ, Inc. Previously, he held positions as the Chief Executive Officer & Director at Adastra Pharmaceuticals, Inc., Marketing Director at Yamanouchi Pharma America, Inc., Principal at Bristol Myers Squibb Co., Vice President-Pain Therapeutic Area at Cephalon, Inc., Vice President-Marketing at Adolor Corp., and Senior Vice President-Commercial at Traws Pharma, Inc. He obtained his undergraduate degree from Pittsburg State University.

Scott T. Megaffin active positions

CompaniesPositionStart
Director/Board Member -
Chief Executive Officer 2021-12-31

Former positions of Scott T. Megaffin

CompaniesPositionEnd
Corporate Officer/Principal -
Chief Executive Officer -
Sales & Marketing -
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
Yamanouchi Pharma America, Inc.
Sales & Marketing -
See the detail of Scott T. Megaffin's experience

Training of Scott T. Megaffin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

26

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Yamanouchi Pharma America, Inc.

Health Technology

  1. Stock Market
  2. Insiders
  3. Scott T. Megaffin